Plant Metabolites in Improving Drug’s Oral Bioavailability

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Biopharmaceutics".

Deadline for manuscript submissions: closed (31 July 2021) | Viewed by 382

Special Issue Editor


E-Mail Website
Guest Editor
Laboratory of Pharmacological Researches, N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry (NIOCH SB RAS), Novosibirsk 630090, Russia
Interests: pharmaceutical development; host-guest complexes; medicinal and pharmaceutical chemistry; drug discovery; pharmacology; pharmaceutical formulation; toxicology; medicinal chemistry; biomedical materials
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

It is well-known that one of the most famous and convenient routes of drug introduction into the human body is oral administration. Nevertheless, this route is the most challenging and complex one, as it requires an opposite property such as water and lipid solubility in one chemical molecule for the drug to be successful. Of course, it is extremely hard for this to be applied in practice since most effective drugs are lipophilic compounds. This is usually the reason for their low bioavailability, together with other impacts, such as presystemic and first-pass metabolism. To overcome this problem, different approaches may be applied. One of them is the usage of different plant metabolites that can form supramolecular systems with drugs and increase their water solubility and oral bioavailability. In contrast to inert chemical carriers which are used mainly to improve water dissolution, such metabolites can additionally act directly on the intestinal epithelium and increase bioavailability via several mechanisms. The aim of this Special Issue is to highlight recent advances in this field, including in vivo and in vitro research.

Dr. Mikhail V. Khvostov
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • drug delivery
  • plant metabolites
  • bioavailability
  • supramolecular complexes
  • water solubility
  • pharmacokinetics
  • oral introduction

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop